Press release content from Business Wire. The AP news staff was not involved in its creation.
Venatorx Pharmaceuticals Names New Head of Regulatory Affairs
January 28, 2021 GMT
Chitrananda Abeygunawardana, Ph.D. Vice President, Regulatory Affairs at Venatorx Pharmaceuticals, Inc. (Photo: Business Wire)
MALVERN, Pa. (BUSINESS WIRE) Jan 28, 2021
Venatorx Pharmaceuticals today announced that Chitrananda Abeygunawardana, Ph.D. has been named Vice President, Regulatory Affairs. With nearly 25 years’ experience in pharmaceutical research, regulatory affairs and compliance, Dr. Abey will be responsible for developing and executing all regulatory strategies and tactics for Venatorx’s antibacterial and antiviral programs including interacting with health authorities and managing clinical trial applications worldwide.